Chest Medicine
Podcast: Interstitial Lung Disease
23 Jun, 2020 | 08:16h | UTC#221 Interstitial Lung Disease with Erin Narewski DO – The Curbsiders Internal Medicine Podcast
Study: Coronavirus Antibodies Can Disappear After a Few Months
21 Jun, 2020 | 23:46h | UTCClinical and immunological assessment of asymptomatic SARS-CoV-2 infections – Nature Medicine
Commentaries: Chinese study: Antibodies in COVID-19 patients fade quickly – CIDRAP AND Coronavirus antibodies may disappear 2 to 3 months after people recover, a new study found – Business Insider AND New insights can change everything we know about coronavirus antibodies – BGR – News Beezer AND Expert reaction to study looking at the immune response of 37 asymptomatic people with confirmed SARS-CoV-2 infection – Science Media Centre AND You May Have Antibodies After Coronavirus Infection. But Not for Long – The New York Times
NIH Halts Clinical Trial of Hydroxychloroquine
21 Jun, 2020 | 23:44h | UTCNIH halts clinical trial of hydroxychloroquine – NIH News Releases
Feasibility and Physiological Effects of Prone Positioning in Non-intubated Patients with Acute Respiratory Failure due to COVID-19
21 Jun, 2020 | 23:34h | UTCCommentaries: Prone positioning in non-intubated patients with COVID-19: raising the bar – The Lancet Respiratory Medicine AND Prone position ups oxygenation in patients with severe COVID-19 – MedicalXpress
Related: Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure (related study and guideline) AND Awake prone positioning in COVID-19 – Thorax
Prevalence of Taste and Smell Dysfunction in Coronavirus Disease 2019
21 Jun, 2020 | 23:29h | UTC
Related Commentary on Twitter
Prevalence of Taste and Smell Dysfunction #COVID19
This survey study published @JAMANetwork of 204 patients with coronavirus disease 2019 found that taste reduction was present in 55.4% of patients, whereas smell reduction was present in 41.7% of patientshttps://t.co/aQ45uD6GAD— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) June 18, 2020
ACP: Advice on Use of N95, Surgical, and Cloth Masks to Prevent COVID-19
19 Jun, 2020 | 09:47h | UTC
Perspective: COVID-19 Is Far More Lethal Than Influenza
19 Jun, 2020 | 09:43h | UTCCOVID-19 Is Far More Lethal Than Influenza – Medium
[Preprint] Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection
19 Jun, 2020 | 09:36h | UTCLimited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection – medRxiv
Related Commentary on Twitter
Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection | pre-peer review in @medrxivpreprint colleagues from @UTSWInfDis remind us that bacterial co-infections are UNCOMMON in #Covid_19 so don’t use antibiotics! https://t.co/dpNLRZiOZn
— Carlos del Rio (@CarlosdelRio7) June 18, 2020
Depression, Pain, Breathing Problems—and That’s After Surviving COVID-19
19 Jun, 2020 | 09:37h | UTCDepression, Pain, Breathing Problems—and That’s After Surviving COVID-19 – Global Health NOW
Related: Report Suggests Some ‘Mildly Symptomatic’ Covid-19 Patients Endure Serious Long-Term Effects (other commentaries on the subject)
Blood Type Linked to Outcomes in Covid-19 Patients: Type O May Be Protective and Type A May Increase Risk
18 Jun, 2020 | 09:12h | UTCCommentary: Study ties blood type to COVID-19 risk; O may help, A hurt – Associated Press
Study: Face Mask Policies May Have Averted as Many as 230,000–450,000 Covid-19 Cases in the US
18 Jun, 2020 | 09:10h | UTCCommentary: Face mask requirements may have prevented 450,000 coronavirus cases – BGR
Related Commentary on Twitter
New study in @Health_Affairs: data suggest that the 15 states and DC that mandated mask-wearing in public between 4/8 and 5/15 averted as many as 230,000–450,000 #covid19 cases.
Wear your mask. Keep your distance. It's not politics; it's science. https://t.co/JUQNJg5DqH
— Zeke Emanuel (@ZekeEmanuel) June 17, 2020
Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure
18 Jun, 2020 | 09:07h | UTCInvited Commentary: Prone Positioning in Awake, Nonintubated Patients With COVID-19: Necessity Is the Mother of Invention – JAMA Internal Medicine
ACP Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination with Azithromycin for the Prophylaxis or Treatment of COVID-19?
18 Jun, 2020 | 08:59h | UTC
WHO To Include Dexamethasone in Updated COVID-19 Care Guidelines; Drops Hydroxychloroquine from Massive Solidarity Trial
18 Jun, 2020 | 09:02h | UTCSee also: WHO drops hydroxychloroquine from Covid-19 clinical trial – STAT AND WHO halts malaria drug study, eyes steroid for COVID-19 – CIDRAP AND Steroid should be kept for serious coronavirus cases, WHO says – Reuters
Position Paper: Guidance on Diagnosis, Prevention and Treatment of Thromboembolic Complications in COVID-19
18 Jun, 2020 | 09:03h | UTC
CDC Report: Characteristics Associated with Hospitalization Among Patients with COVID-19
18 Jun, 2020 | 08:57h | UTCCommentary: Black Patients With COVID-19 in Atlanta More Likely to Be Hospitalized: CDC – Reuters
No Symptoms in 37% of COVID-19 Nursing Home Patients, Research Finds
18 Jun, 2020 | 08:56h | UTCNo symptoms in 37% of COVID-19 nursing home patients, research finds – CIDRAP
Randomized Trial: Dexamethasone Reduces Death by Up to One Third in Patients with Severe COVID-19
17 Jun, 2020 | 02:49h | UTCCommentaries: Coronavirus breakthrough: dexamethasone is first drug shown to save lives – Nature AND WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients – World Health Organization AND Major study finds common steroid reduces deaths among patients with severe Covid-19 – STAT AND Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19 – University of Oxford AND Coronavirus: Dexamethasone proves first life-saving drug – BBC
Related Commentary on Twitter
Dexamethasone reduced deaths by 1/3rd in ventilated patients (rate ratio 0.65 [95% CI 0.48 to 0.88]; p=0.0003) and by 1/5th in patients receiving oxygen only (0.80 [0.67 to 0.96]; p=0.0021). No benefit in patients not requiring respiratory support (1.22 [0.86 to 1.75; p=0.14).
— Peter Horby @peterhorby.bsky.social (@PeterHorby) June 16, 2020
How Deadly is the Coronavirus? Scientists are Close to an Answer
17 Jun, 2020 | 02:44h | UTCHow deadly is the coronavirus? Scientists are close to an answer – Nature
A Visual Guide to the SARS-CoV-2 Coronavirus
17 Jun, 2020 | 02:46h | UTCA Visual Guide to the SARS-CoV-2 Coronavirus – Scientific American
Cohort Study: Ibuprofen Use Not Associated with Worse Outcomes in Covid-19 Patients
17 Jun, 2020 | 02:41h | UTCIbuprofen use and clinical outcomes in COVID-19 patients – Clinical Microbiology and Infection
Related Commentary on Twitter
A new cohort @CMIJournal :
403 COVID-19 patients, Ibuprofen use was NOT associated with worse clinical outcomes, compared to paracetamol or no antipyretic
Ibuprofen use and clinical outcomes in #COVID19 patients.
⛔Median age : 45, younghttps://t.co/Y4WL2UsIDU— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) June 12, 2020
How to Avoid the Virus as the World Reopens
16 Jun, 2020 | 08:24h | UTCHow to avoid the virus as the world reopens – Financial Times
CDC Report: Hospitalizations for Covid-19 Six Times Higher and Deaths 12 times Higher Among Those with Underlying Conditions
16 Jun, 2020 | 08:19h | UTCCommentary: COVID-19 patients with underlying health conditions are 12 times more likely to die: CDC – The Hill
Video: Coronavirus Q&A: Clinical Update with Carlos del Rio, MD
16 Jun, 2020 | 08:21h | UTCCoronavirus Q&A: Clinical Update with Carlos del Rio, MD
COVID-19 Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine
16 Jun, 2020 | 08:10h | UTCCommentaries: FDA Withdraws Emergency Use Authorization For Hydroxychloroquine – NPR AND FDA revokes authorization of drug Trump touted – CNN